Fingerprint
Dive into the research topics of 'TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study
PanCareLIFE Consortium
- Princess Maxima Center for Pediatric Oncology
- Erasmus University Medical Center
- University of Alberta
- Visceral and Transplant Surgery - University Medical Center of the Johannes Gutenberg-University Mainz
- Boyne Research Institute
- Department of Neurooncology
- Danish Cancer Society Research Center
- Copenhagen University Hospital Rigshospitalet
- Aarhus University
- University Hospital Brno
- Charles University
- University of Bern
- University of Münster
- University Children's Hospital Muenster
- St Antonius Hospital Nieuwegein and University Medical Center Utrecht
- Epidemiology and Biostatistics Unit and DOPO Clinic
- Medizinische Universität Graz
- Stuttgart Cancer Center
- BC Children's Hospital Research Institute
- BC Children's Hospital